Nonclinical Efficacy Testing » Non-Clinical CROs and Agencies » AnaPath Research

AnaPath Research

Table of Contents
Table of Contents

AnaPath Research is a global CRO based near Barcelona, providing research and development services for various industries including pharmaceuticals, biotechnology, agriculture, and chemistry. This article investigates and summarizes the company's features and information on its disease models.

Non-clinical studies undertaken by AnaPath Research

Conduct a comprehensive safety evaluation

At AnaPath Research, to confirm the safety of new drug candidates,Supports a wide range of in vivo (in the body) testsWe can handle general repeated-dose toxicity studies, reproductive and developmental toxicity studies, and safety pharmacology studies evaluating the central nervous system and cardiovascular system.A specialized team with extensive experience conducts comprehensive risk assessments from the initial stage.We support the development of pharmaceuticals by doing this.

Analysis for biopharmaceuticals

In addition to low-molecular-weight compounds, recombinant proteins, monoclonal antibodies, gene therapy drugs, and otherProvision of analytical services for biologics (biopharmaceuticals)We are engaged in a wide range of specialized bioanalytical services to meet regulatory requirements. This includes method development and validation for pharmacokinetics (PK) and toxicokinetics (TK), as well as measurement of anti-drug antibodies (ADAs) and quantification of biomarkers.

Quality standards based on GLP compliance and AAALAC accreditation

The company is the standard for conducting drug safety tests.GLP (Good Laboratory Practice) certified facilityand we provide reliable test data. Furthermore,Accreditation from AAALAC, an international animal welfare organizationWe also have strict auditing systems in place, implemented by a quality assurance team with many years of experience, ensuring ethical and appropriate handling.

An example of a pathology model held by AnaPath Research

We select and utilize diverse animal models.

AnaPath Research is a CRO that conducts studies directly at its own facilities. For safety assessments and toxicity testing, we appropriately select and utilize a diverse range of animal models, from rodents (rats and mice) to non-rodents (dogs, minipigs, and non-human primates), depending on the characteristics of each compound.

AnaPath Research Non-clinical Study Case

With a track record of safety evaluation testing for various compounds.

While AnaPath Research's official website does not feature specific non-clinical study examples, the company conducts safety evaluation studies for a wide range of compounds.

Due to confidentiality of individual sponsor names and specific development compounds in safety assessment studies, detailed study examples are not disclosed. However, from the era of its predecessor testing facility, the company has decades of experience in conducting GLP-compliant studies across a wide range of fields, including pharmaceuticals, medical devices, and agricultural chemicals, and has a proven track record of contributing to regulatory applications in various countries.

AnaPath Research Company Information

Address Barcelona, Spain
Tel +34 93 719 03 61
Website https://www.anapathresearch.com/

3 Recommended Contract Research Organizations
for Non-Clinical Studies
— by Target goal and Expertise

In non-clinical development, the choice of contract research organization shapes the quality of the data and the time it takes to reach the next decision. Below, three CROs are introduced by the type of study they support: pharmacology (efficacy) studies, safety studies, and pharmacokinetic (PK/PD) studies. Each summary describes the services the company offers so that you can match a provider to your target and development objective.

Pharmacology (Efficacy) StudiesDisease-Relevant Models for
Translational Drug Evaluation
SMC Laboratories, Inc.
Reference: SMC Laboratories, Inc. official website (https://www.smccro-lab.com/)

SMC Laboratories, Inc.

SMC Laboratories is a specialized non-clinical CRO focused on in vivo pharmacology and efficacy studies using disease-relevant animal models, particularly in fibrosis, inflammation, metabolic diseases, and oncology.

Areas of Expertise
Disease-Relevant Model Portfolio

SMC Laboratories offers models covering the liver, lung, kidney, intestine, and oncology. Its portfolio includes the proprietary STAM™ model for MASH, fibrosis, and hepatocellular carcinoma.

Study Design Based on Target Biology

Study plans are developed around the target biology, mechanism of action, disease stage, and development objective. Pharmacological endpoints can be combined with histopathology, biomarkers, and disease-specific readouts.

Support from Target Validation to Proof of Concept

With experience from more than 1,000 studies for clients in 30 countries, SMC Laboratories supports programs from target validation and candidate selection through in vivo proof-of-concept studies.

Safety StudiesComprehensive Safety Assessment for
Preclinical Development
Charles River Laboratories
Reference: Charles River Laboratories official website (https://www.criver.com/)

Charles River Laboratories

Charles River provides non-clinical toxicology and safety assessment services for programs ranging from exploratory safety studies to IND-enabling development.

Areas of Expertise
General Toxicology Across Study Designs

Services include single- and repeat-dose toxicology, dose-range finding, and general toxicology studies across multiple species and administration routes.

Non-GLP and GLP Study Support

Charles River supports both non-GLP and GLP studies, allowing sponsors to progress from early safety characterization to studies intended for regulatory submissions.

Integrated IND-Enabling Safety Assessment

Toxicology studies can be integrated with toxicokinetics, clinical pathology, histopathology, and safety pharmacology to support interpretation and IND-enabling safety packages.

Pharmacokinetic (PK/PD) StudiesConnecting Drug Exposure with
Pharmacological Response
Inotiv
Reference: Inotiv official website (https://www.inotiv.com/)

Inotiv

Inotiv provides integrated PK/PD, DMPK, and bioanalytical services to characterize drug exposure and its relationship with pharmacological response.

Areas of Expertise
Pharmacokinetic Characterization

PK studies characterize exposure, half-life, clearance, and other pharmacokinetic parameters needed to understand how a candidate behaves in the selected model.

Exposure–Response Evaluation

Pharmacokinetic data can be combined with pharmacodynamic endpoints and bioanalysis to evaluate the relationship between drug exposure and pharmacological response.

Integrated DMPK and Development Support

Integrated DMPK, pharmacology, and safety information supports candidate comparison, dose selection, dosing-frequency optimization, and decisions about subsequent preclinical development.

By Therapeutic Area
Disease Animal Models
and Reviews
Proven Capability, Expertise and Track Record
Top 3 Non-Clinical CRO Services